Terms: = Liver cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
25 results:
1. Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
Weng Y; Wang L; Wang XY; Fan XX; Yan L; Li ZH; Zhang SL
Front Endocrinol (Lausanne); 2023; 14():1115893. PubMed ID: 37745701
[TBL] [Abstract] [Full Text] [Related]
2. Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis.
Siesing C; Petersson A; Ulfarsdottir T; Chattopadhyay S; Nodin B; Eberhard J; Brändstedt J; Syk I; Gisselsson D; Jirström K
Mod Pathol; 2022 Jul; 35(7):979-988. PubMed ID: 35169225
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Metachronous Quintuple cancer Involving the Stomach, Rectum, Colon, liver and Prostate].
Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Sakamoto T; Shinke G; Taguchi I; Nagano T; Kawai K; Kitahara T; Hiraki M; Masuzawa T; Takeno A; Hata T; Murata K
Gan To Kagaku Ryoho; 2021 Apr; 48(4):608-611. PubMed ID: 33976064
[TBL] [Abstract] [Full Text] [Related]
4. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
Seppälä TT; Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vida JB; Kariv R; Rosner G; Piñero TA; Pavicic W; Kalfayan P; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Redler S; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Hopper JL; Win AK; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Wadt KAW; Mourits MJE; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Rokkones E; Sampson JR; Evans DG; Møller P
Eur J Cancer; 2021 May; 148():124-133. PubMed ID: 33743481
[TBL] [Abstract] [Full Text] [Related]
5. [18F]FDG PET/MRI in rectal cancer.
Crimì F; Valeggia S; Baffoni L; Stramare R; Lacognata C; Spolverato G; Albertoni L; Spimpolo A; Evangelista L; Zucchetta P; Cecchin D; Pucciarelli S
Ann Nucl Med; 2021 Mar; 35(3):281-290. PubMed ID: 33517562
[TBL] [Abstract] [Full Text] [Related]
6. Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma.
Patil NR; Khan GN
Am J Case Rep; 2020 Jul; 21():e923803. PubMed ID: 32658872
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic cancer Patients Receiving Neoadjuvant treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
8. Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice.
Roque-Lima B; Roque CCTA; Begnami MD; Peresi P; Lima ENP; Mello CAL; Coimbra FJ; Chojniak R; Goss Santos T
J Drug Target; 2019 Nov; 27(9):943-949. PubMed ID: 30088428
[TBL] [Abstract] [Full Text] [Related]
9. Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.
Tóth C; Sükösd F; Valicsek E; Herpel E; Schirmacher P; Renner M; Mader C; Tiszlavicz L; Kriegsmann J
Int J Mol Med; 2017 Nov; 40(5):1457-1465. PubMed ID: 28949378
[TBL] [Abstract] [Full Text] [Related]
10. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
[TBL] [Abstract] [Full Text] [Related]
11. [Characteristics and Outcomes of treatment in Patients with Stage IV Colorectal cancer with Mismatch Repair Deficiency].
Ishibashi K; Chika N; Suzuki O; Ito T; Amano K; Kumamoto K; Fukuchi M; Kumagai Y; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1711-1714. PubMed ID: 28133107
[TBL] [Abstract] [Full Text] [Related]
12. Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.
Zhu X; Li D; Zhang Z; Zhu W; Li W; Zhao J; Xing X; He Z; Wang S; Wang F; Ma L; Bai Q; Zeng X; Li J; Gao C; Xiao Y; Wang Q; Chen L; Chen W
Mol Carcinog; 2017 May; 56(5):1449-1460. PubMed ID: 27996159
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic biomarkers for metastatic colorectal cancer].
Neumann JH
Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
[TBL] [Abstract] [Full Text] [Related]
14. In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma.
Cao Y; Chen Y; Huang Y; Liu Z; Li G
Ir J Med Sci; 2017 May; 186(2):257-263. PubMed ID: 26782688
[TBL] [Abstract] [Full Text] [Related]
15. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
[TBL] [Abstract] [Full Text] [Related]
16. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract] [Full Text] [Related]
17. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.
He Z; Subramaniam D; Ramalingam S; Dhar A; Postier RG; Umar S; Zhang Y; Anant S
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G929-37. PubMed ID: 21836060
[TBL] [Abstract] [Full Text] [Related]
18. Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis.
Hanada M; Takasu H; Kitaura M
Oncol Rep; 2010 Oct; 24(4):1011-8. PubMed ID: 20811683
[TBL] [Abstract] [Full Text] [Related]
19. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
[TBL] [Abstract] [Full Text] [Related]
20. Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.
Dejeux E; Audard V; Cavard C; Gut IG; Terris B; Tost J
J Mol Diagn; 2007 Sep; 9(4):510-20. PubMed ID: 17690210
[TBL] [Abstract] [Full Text] [Related]
[Next]
